{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:19:01Z","timestamp":1784589541842,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antibiotics have been associated with several individual autoimmune diseases (ADs). This study aims to discover whether pre-diagnostic antibiotics are associated with the onset of ADs in general.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From a cohort of 11,407 children, 242 developed ADs (type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis (JIA), or inflammatory bowel diseases) by a median age of 16 years. Antibiotic purchases from birth until the date of diagnosis (or respective date in the matched controls <jats:italic>n<\/jats:italic>\u2009=\u2009708) were traced from national registers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Total number of antibiotic purchases was not related to the onset of ADs when studied as a group. Of specific diagnoses, JIA was associated with the total number of antibiotics throughout the childhood and with broad-spectrum antibiotics before the age of 3 years. Intriguingly, recent and frequent antibiotic use (within 2 years before diagnosis and \u22653 purchases) was associated with the onset of ADs (OR 1.72, 95% CI 1.08\u20132.74). Regardless of frequent use in childhood (40% of all antibiotics), penicillin group antibiotics were not related to any ADs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Use of antibiotics was relatively safe regarding the overall development of ADs. However, broad-spectrum antibiotics should be used considerately as they may associate with an increased likelihood of JIA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Increasing numbers of antibiotic purchases before the age of 3 years or throughout childhood were not associated with the development of pediatric autoimmune diseases.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Broad-spectrum antibiotics were related to the development of autoimmune diseases, especially juvenile idiopathic arthritis in children, while penicillin group antibiotics were not.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>The use of broad-spectrum antibiotics in children should be cautious as they may carry along a risk for autoimmune disease development.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-022-02188-4","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T14:02:57Z","timestamp":1658239377000},"page":"1096-1104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case\u2013control study"],"prefix":"10.1038","volume":"93","author":[{"given":"Laura K.","family":"R\u00e4is\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohvi E.","family":"K\u00e4\u00e4ri\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"Sund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Engberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli T.","family":"Viljakainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaija-Leena","family":"Kolho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"2188_CR1","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/gut.2009.199679","volume":"60","author":"CW Lees","year":"2011","unstructured":"Lees, C. W., Barrett, J. C., Parkes, M. & Satsangi, J. New IBD genetics: common pathways with other diseases. Gut. 60, 1739\u20131753 (2011).","journal-title":"Gut"},{"key":"2188_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/gm305","volume":"4","author":"C Richard-Miceli","year":"2012","unstructured":"Richard-Miceli, C. & Criswell, L. A. Emerging patterns of genetic overlap across autoimmune disorders. Genome Med. 4, 6 (2012).","journal-title":"Genome Med."},{"key":"2188_CR3","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1530\/EC-17-0347","volume":"7","author":"SA Paschou","year":"2017","unstructured":"Paschou, S. A., Papadopoulou-Marketou, N., Chrousos, G. & Kanaka-Gantenbein, C. On type 1 diabetes mellitus pathogenesis. Endocr. Connect. 7, R38\u2013R46 (2017).","journal-title":"Endocr. Connect."},{"key":"2188_CR4","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese, A. Autoreactive T cells in type 1 diabetes. J. Clin. Investig. 127, 2881\u20132891 (2017).","journal-title":"J. Clin. Investig."},{"key":"2188_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2014","unstructured":"Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A. & Fallahi, P. Autoimmune thyroid disorders. Autoimmun. Rev. 14, 174\u2013180 (2014).","journal-title":"Autoimmun. Rev."},{"key":"2188_CR6","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken, B., Albani, S. & Martini, A. Juvenile idiopathic arthritis. Lancet 377, 2238\u20132149 (2011).","journal-title":"Lancet"},{"key":"2188_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10620-017-4892-4","volume":"63","author":"P Giuffrida","year":"2017","unstructured":"Giuffrida, P., Corazza, G. R. & Di Sabatino, A. Old and new lymphocyte players in inflammatory bowel disease. Dig. Dis. Sci. 63, 277\u2013288 (2017).","journal-title":"Dig. Dis. Sci."},{"key":"2188_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1586\/eci.10.34","volume":"6","author":"F van Wijk","year":"2010","unstructured":"van Wijk, F. & Cheroutre, H. Mucosal T cells in gut homeostasis and inflammation. Expert Rev. Clin. l Immunol. 6, 559\u2013566 (2010).","journal-title":"Expert Rev. Clin. l Immunol."},{"key":"2188_CR9","doi-asserted-by":"publisher","first-page":"9653","DOI":"10.3748\/wjg.v20.i29.9653","volume":"20","author":"ER Mann","year":"2014","unstructured":"Mann, E. R. & Li, X. Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol. 20, 9653 (2014).","journal-title":"World J. Gastroenterol."},{"key":"2188_CR10","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","volume":"69","author":"P Paone","year":"2020","unstructured":"Paone, P. & Cani, P. D. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut 69, 2232\u20132243 (2020).","journal-title":"Gut"},{"key":"2188_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/08916930701619169","volume":"41","author":"C Taplin","year":"2008","unstructured":"Taplin, C. & Barker, J. Autoantibodies in type 1 diabetes. Autoimmunity 41, 11\u201318 (2008).","journal-title":"Autoimmunity"},{"key":"2188_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","volume":"8","author":"E Fr\u00f6hlich","year":"2017","unstructured":"Fr\u00f6hlich, E. & Wahl, R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 8, 521 (2017).","journal-title":"Front Immunol."},{"key":"2188_CR13","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.3389\/fimmu.2018.03168","volume":"9","author":"SA Mahmud","year":"2019","unstructured":"Mahmud, S. A. & Binstadt, B. A. Autoantibodies in the pathogenesis, diagnosis, and prognosis of juvenile idiopathic arthritis. Front Immunol. 9, 3168 (2019).","journal-title":"Front Immunol."},{"key":"2188_CR14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3748\/wjg.v22.i3.1304","volume":"22","author":"K Mitsuyama","year":"2016","unstructured":"Mitsuyama, K. et al. Antibody markers in the diagnosis of inflammatory bowel disease. World J. Gastroenterol. 22, 1304 (2016).","journal-title":"World J. Gastroenterol."},{"key":"2188_CR15","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00431-021-03987-3","volume":"180","author":"L R\u00e4is\u00e4nen","year":"2021","unstructured":"R\u00e4is\u00e4nen, L., Viljakainen, H., Sarkkola, C. & Kolho, K. L. Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases. Eur. J. Pediatr. 180, 2115\u20132123 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"2188_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri, M. et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot. Perspect. 10, 98 (2020).","journal-title":"Health Promot. Perspect."},{"key":"2188_CR17","first-page":"2460","volume":"30","author":"E Savolainen","year":"2003","unstructured":"Savolainen, E., Kaipiainen-Sepp\u00e4nen, O., Kr\u00f6ger, L. & Luosuj\u00e4rvi, R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 Arthritis Survey. J. Rheumatol. 30, 2460\u20132468 (2003).","journal-title":"J. Rheumatol."},{"key":"2188_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/03009740601089259","volume":"36","author":"C Pruunsild","year":"2007","unstructured":"Pruunsild, C. et al. Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand. J. Rheumatol. 36, 7\u201313 (2007).","journal-title":"Scand. J. Rheumatol."},{"key":"2188_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","volume":"7","author":"J Burisch","year":"2013","unstructured":"Burisch, J., Jess, T., Martinato, M. & Lakatos, P. L. The burden of inflammatory bowel disease in Europe. J. Crohns Colitis 7, 322\u2013337 (2013).","journal-title":"J. Crohns Colitis"},{"key":"2188_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/apm.12023","volume":"121","author":"A Kondrashova","year":"2013","unstructured":"Kondrashova, A., Seiskari, T., Ilonen, J., Knip, M. & Hy\u00f6ty, H. The \u201cHygiene hypothesis\u201d and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS 121, 478\u2013493 (2013).","journal-title":"APMIS"},{"key":"2188_CR21","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/apa.14874","volume":"108","author":"N Mustonen","year":"2019","unstructured":"Mustonen, N. et al. Early childhood infections and the use of antibiotics and antipyretic-analgesics in Finland, Estonia and Russian Karelia. Acta Paediatr. 108, 2075\u20132082 (2019).","journal-title":"Acta Paediatr."},{"key":"2188_CR22","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1542\/peds.2015-0036","volume":"136","author":"DB Horton","year":"2015","unstructured":"Horton, D. B. et al. Antibiotic exposure and juvenile idiopathic arthritis: a case-control study. Pediatrics (Evanst.) 136, e333\u2013e343 (2015).","journal-title":"Pediatrics (Evanst.)"},{"key":"2188_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3899\/jrheum.140348","volume":"42","author":"M Arvonen","year":"2015","unstructured":"Arvonen, M., Virla, L., Pokka, T., Kr\u00f6ger, L. & V\u00e4h\u00e4salo, P. Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group\u2019s greater susceptibility to infections? J. Rheumatol. 42, 521\u2013526 (2015).","journal-title":"J. Rheumatol."},{"key":"2188_CR24","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1542\/peds.2011-3886","volume":"130","author":"MP Kronman","year":"2012","unstructured":"Kronman, M. P., Zaoutis, T. E., Haynes, K., Feng, R. & Coffin, S. E. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130, e794\u2013e803 (2012).","journal-title":"Pediatrics"},{"key":"2188_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/aje\/kwr400","volume":"175","author":"L Virta","year":"2012","unstructured":"Virta, L., Auvinen, A., Helenius, H., Huovinen, P. & Kolho, K. L. Association of repeated exposure to antibiotics with the development of pediatric Crohn\u2019s disease\u2014a nationwide, register-based Finnish case-control study. Am. J. Epidemiol. 175, 775\u2013784 (2012).","journal-title":"Am. J. Epidemiol."},{"key":"2188_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2337\/dc19-1162","volume":"43","author":"ML Wernroth","year":"2020","unstructured":"Wernroth, M. L. et al. Early childhood antibiotic treatment for otitis media and other respiratory tract infections is associated with risk of type 1 diabetes: a nationwide register- based study with sibling analysis. Diabetes Care. 43, 991\u2013999 (2020).","journal-title":"Diabetes Care."},{"key":"2188_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapediatrics.2017.2905","volume":"171","author":"KM Kemppainen","year":"2017","unstructured":"Kemppainen, K. M. et al. Association between early-life antibiotic use and the risk of islet or celiac disease autoimmunity. JAMA Pediatr. 171, 1217\u20131225 (2017).","journal-title":"JAMA Pediatr."},{"key":"2188_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpeds.2016.03.034","volume":"173","author":"AJ Pollock","year":"2016","unstructured":"Pollock, A. J., Seibert, T. & Allen, D. B. Severe and persistent thyroid dysfunction associated with tetracycline-antibiotic treatment in youth. J. Pediatr. 173, 232\u2013234 (2016).","journal-title":"J. Pediatr."},{"key":"2188_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ije\/dyy189","volume":"48","author":"RAO Figueiredo","year":"2019","unstructured":"Figueiredo, R. A. O. et al. Cohort profile: The Finnish Health in Teens (Fin-HIT) study: a population-based study. Int J. Epidemiol. 48, 23\u201324h (2019).","journal-title":"Int J. Epidemiol."},{"key":"2188_CR30","unstructured":"Niemel\u00e4, H. Social Security in Finland (Helsinki, Finland, Social Insurance Institution (KELA), Finnish Centre for Pensions (ETK), Finnish Pension Alliance (TELA), and Finnish Ministry of Social Affairs and Health, 2006)."},{"key":"2188_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu, K. et al. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin. Pharm. Toxicol. 106, 86\u201394 (2010).","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"2188_CR32","doi-asserted-by":"crossref","unstructured":"Rose, S. & van der Laan, M. J. Why match? Investigating matched case-control study designs with causal effect estimation. Int. J. Biostat. 5, Article 1 (2009).","DOI":"10.2202\/1557-4679.1127"},{"key":"2188_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/dme.13262","volume":"34","author":"KH Mikkelsen","year":"2017","unstructured":"Mikkelsen, K. H. et al. Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study. Diabet. Med. 34, 272 (2017).","journal-title":"Diabet. Med."},{"key":"2188_CR34","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/pedi.13111","volume":"21","author":"JC Antvorskov","year":"2020","unstructured":"Antvorskov, J. C. et al. Antibiotic treatment during early childhood and risk of type 1 diabetes in children: a national birth cohort study. Pediatr. Diabetes 21, 1457\u20131464 (2020).","journal-title":"Pediatr. Diabetes"},{"key":"2188_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12969-021-00611-4","volume":"19","author":"E Kindgren","year":"2021","unstructured":"Kindgren, E. & Ludvigsson, J. Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study. Pediatr. Rheumatol. 19, 145 (2021).","journal-title":"Pediatr. Rheumatol."},{"key":"2188_CR36","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/ajg.2010.398","volume":"105","author":"SY Shaw","year":"2010","unstructured":"Shaw, S. Y., Blanchard, J. F. & Bernstein, C. N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am. J. Gastroenterol. 105, 2687\u20132692 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"2188_CR37","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/ajg.2014.246","volume":"109","author":"R Ungaro","year":"2014","unstructured":"Ungaro, R. et al. Antibiotics associated with increased risk of New-Onset Crohn\u2019s disease but not ulcerative colitis: a meta-analysis. Am. J. Gastroenterol. 109, 1728\u20131738 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"2188_CR38","doi-asserted-by":"crossref","unstructured":"Duong, Q. A., Pittet, L. F., Curtis, N. & Zimmermann P. Antibiotic exposure and adverse long-term health outcomes in children: a systematic review and meta-analysis. J. Infect. S0163445322000044, online ahead of print (2022).","DOI":"10.1016\/j.jinf.2022.01.005"},{"key":"2188_CR39","first-page":"20143085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon, A. K., Hollander, G. A. & McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci. 282, 20143085 (2015).","journal-title":"Proc. Biol. Sci."},{"key":"2188_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova, L. N. et al. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr. Rheumatol. 19, 135 (2021).","journal-title":"Pediatr. Rheumatol."},{"key":"2188_CR41","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1172\/JCI200114235","volume":"108","author":"KW Wucherpfennig","year":"2001","unstructured":"Wucherpfennig, K. W. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. 108, 1097\u20131104 (2001).","journal-title":"J. Clin. Invest."},{"key":"2188_CR42","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1016\/S2214-109X(20)30079-6","volume":"8","author":"G Allwell-Brown","year":"2020","unstructured":"Allwell-Brown, G. et al. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005\u201317: a systematic analysis of 132 national surveys from 73 countries. Lancet Glob. Health 8, e799\u2013e807 (2020).","journal-title":"Lancet Glob. Health"},{"key":"2188_CR43","doi-asserted-by":"publisher","first-page":"815703","DOI":"10.3389\/fendo.2022.815703","volume":"13","author":"C Ross","year":"2022","unstructured":"Ross, C. et al. The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: a global scoping review. Front Endocrinol. 13, 815703 (2022).","journal-title":"Front Endocrinol."},{"key":"2188_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12969-021-00650-x","volume":"19","author":"SM Al-Mayouf","year":"2021","unstructured":"Al-Mayouf, S. M. et al. Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East. Pediatr. Rheumatol. 19, 166 (2021).","journal-title":"Pediatr. Rheumatol."},{"key":"2188_CR45","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2021.12.282","volume":"162","author":"ME Kuenzig","year":"2022","unstructured":"Kuenzig, M. E. et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology 162, 1147\u20131159 (2022).","journal-title":"Gastroenterology"},{"key":"2188_CR46","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger, C. et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Inf. Dis. 18, 1191\u20131210 (2018).","journal-title":"Lancet Inf. Dis."},{"key":"2188_CR47","first-page":"489","volume":"42","author":"H Neuman","year":"2018","unstructured":"Neuman, H., Forsythe, P., Uzan, A., Avni, O. & Koren, O. Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol Rev. 42, 489\u2013499 (2018).","journal-title":"FEMS Microbiol Rev."},{"key":"2188_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-46","volume":"11","author":"M Murri","year":"2013","unstructured":"Murri, M. et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 11, 46 (2013).","journal-title":"BMC Med."},{"key":"2188_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrendo.2015.218","volume":"12","author":"M Knip","year":"2016","unstructured":"Knip, M. & Siljander, H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 12, 154\u2013167 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2188_CR50","first-page":"192","volume":"10","author":"I Cornejo-Pareja","year":"2020","unstructured":"Cornejo-Pareja, I. et al. Differential microbial pattern description in subjects with autoimmune-based thyroid diseases: a pilot study. J. Pres. Med. 10, 192 (2020).","journal-title":"J. Pres. Med."},{"key":"2188_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12826","volume":"294","author":"M Arvonen","year":"2020","unstructured":"Arvonen, M. et al. Microbial orchestra in juvenile idiopathic arthritis: Sounds of disarray? Immunol. Rev. 294, 9\u201326 (2020).","journal-title":"Immunol. Rev."},{"key":"2188_CR52","doi-asserted-by":"crossref","unstructured":"Comito, D. & Romano, C. Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases. Int. J. Inflamm. 2012, 687143\u2013687147 (2012).","DOI":"10.1155\/2012\/687143"},{"key":"2188_CR53","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ajg.2015.149","volume":"110","author":"KL Kolho","year":"2015","unstructured":"Kolho, K. L. et al. Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am. J. Gastroenterol. 110, 921\u2013930 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"2188_CR54","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1017\/ice.2017.94","volume":"38","author":"JS Gerber","year":"2017","unstructured":"Gerber, J. S. et al. Development and application of an antibiotic spectrum index for benchmarking antibiotic selection patterns across hospitals. Infect. Control Hosp. Epidemiol. 38, 993\u2013997 (2017).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"2188_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.arcmed.2017.11.004","volume":"48","author":"T Iizumi","year":"2017","unstructured":"Iizumi, T., Battaglia, T., Ruiz, V. & Perez, G. I. Gut microbiome and antibiotics. Arch. Med. Res. 48, 727\u2013734 (2017).","journal-title":"Arch. Med. Res."},{"key":"2188_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella, E. et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7, 14 (2019).","journal-title":"Microorganisms"},{"key":"2188_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0924-8579(01)00406-X","volume":"18","author":"F Van Bambeke","year":"2001","unstructured":"Van Bambeke, F. & Tulkens, P. M. Macrolides: pharmacokinetics and pharmacodynamics. Int. J. Antimicrobial Agents 18, 17\u201323 (2001).","journal-title":"Int. J. Antimicrobial Agents"},{"key":"2188_CR58","doi-asserted-by":"publisher","first-page":"e035677","DOI":"10.1136\/bmjopen-2019-035677","volume":"10","author":"KT Elvers","year":"2020","unstructured":"Elvers, K. T. et al. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open. 10, e035677 (2020).","journal-title":"BMJ Open."},{"key":"2188_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10410","volume":"7","author":"K Korpela","year":"2016","unstructured":"Korpela, K. et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 7, 10410 (2016).","journal-title":"Nat. Commun."},{"key":"2188_CR60","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","volume":"9","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann, P., Ziesenitz, V. C., Curtis, N. & Ritz, N. The immunomodulatory effects of macrolides\u2014a systematic review of the underlying mechanisms. Front Immunol. 9, 302 (2018).","journal-title":"Front Immunol."},{"key":"2188_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00893-y","volume":"8","author":"SC Raju","year":"2020","unstructured":"Raju, S. C. et al. Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition. Microbiome 8, 1\u2013121 (2020).","journal-title":"Microbiome"},{"key":"2188_CR62","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3389\/fmicb.2018.01136","volume":"9","author":"Z Xun","year":"2018","unstructured":"Xun, Z., Zhang, Q., Xu, T., Chen, N. & Chen, F. Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral bacterial profiles. Front Microbiol. 9, 1136 (2018).","journal-title":"Front Microbiol."},{"key":"2188_CR63","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/aje\/kwr400","volume":"175","author":"L Virta","year":"2012","unstructured":"Virta, L., Auvinen, A., Helenius, H., Huovinen, P. & Kolho, K. L. Association of repeated exposure to antibiotics with the development of pediatric Crohn\u2019s disease-a nationwide, register-based finnish case-control study. Am. J. Epidemiol. 175, 775\u2013784 (2012).","journal-title":"Am. J. Epidemiol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02188-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T18:03:56Z","timestamp":1679508236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02188-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02188-4","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Fin-HIT study protocol was approved by the Ethics Committee of the Hospital District of Helsinki and Uusimaa (decision number 169\/13\/03\/00\/10). Participants and one of their guardians were required to sign an informed written consent form to allow access to the participants\u2019 registers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}